Setting up an osteoporosis fracture liaison service: Background and potential outcomes

Best Practice and Research: Clinical Rheumatology

Volumn 19, Issue 6, 2005, Pages 1081-1094

  Gallacher, Stephen J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone mineral density; Fracture; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; HORMONE; RISEDRONIC ACID; VITAMIN D;

BONE DENSITY; BONE MINERAL; CLINICAL PATHWAY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FOLLOW UP; FRACTURE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH SERVICE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; TREATMENT OUTCOME;

AGED; BONE DENSITY; DELIVERY OF HEALTH CARE; DENSITOMETRY, X-RAY; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGRAM DEVELOPMENT; RISK FACTORS; SCOTLAND;

EID: 28644439551     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2005.07.001     Document Type: Review

References (24)

1. L.J. Melton E.A. Chrischilles C. Cooper et al. How many women have osteoporosis Journal of Bone and Mineral Research 7 1992 1005-1010
2. C. Cooper Epidemiology and definition of osteoporosis In J.E. Compston (ed.) Osteoporosis: New Perspectives on Causes, Prevention and Treatment 1996 Royal College of Physicians of London London 1-10
3. Osteoporosis methodology group and the osteoporosis research advisory group Meta-analyses of therapies for postmenopausal osteoporosis Endocrine Reviews 23 2002 495-578
4. World health Organization Assessment of fracture risk and its application to screening for postmenopausal osteoporosis Technical Report Series 843 1994 WHO Geneva
5. Royal College of Physicians Osteoporosis: Clinical Guidelines for Prevention and Treatment 1999 Royal College of Physicians London
6. Royal College of Physicians Osteoporosis: Clinical Guidelines for Prevention and Treatment. Update on Pharmacological Interventions and an Algorithm for Management 2000 Royal College of Physicians London
7. Scottish Intercollegiate Guidelines Network Management of Osteoporosis SIGN 71 2003 Scottish Intercollegiate Guidelines Network Edinburgh
8. J.A. Kanis O. Johnell C. De Laet et al. A meta-analysis of previous fracture and subsequent fracture risk Bone 35 2004 375-382
9. S.R. Cummings M.C. Nevitt W.S. Browner et al. Risk factors for hip fracture in white women The New England Journal of Medicine 332 1995 767-773
10. B.C. Taylor P.J. Schreiner K.L. Stone et al. Long-term prediction of incident hip fracture risk in elderly white women: Study of osteoporotic fractures Journal of the American Geriatrics Society 52 2004 1479-1486
11. T. Van Staa H.G.M. Leufkens L. Abenhaim et al. Use of oral corticosteroids and risk of fractures Journal of Bone and Mineral Research 15 2000 993-1000
12. P. Garnero E. Hauser M.C. Chapuy et al. Markers of bone turnover predict hip fracture in elderly women. The EPIDOS prospective study Journal of Bone and Mineral Research 11 1996 1531-1538
13. K.E. Ensrud R.C. Lipschutz J.A. Cauley et al. Body size and hip fracture risk in older women: A prospective study. Study of Osteoporotic Fractures Research Group The American Journal of Medicine 103 1997 274-280
14. U.A. Liberman S.R. Weiss J. Broll et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis The New England Journal of Medicine 333 1995 1437-1443
15. D.M. Black S.R. Cummings D.B. Karpf et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1996 1535-1541
16. S.R. Cummings D.M. Black D.E. Thompson et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial The Journal of the American Medical Association 280 1998 2077-2082
17. R. Lindsay S.L. Silverman C. Cooper et al. Risk of new vertebral fracture in the year following a fracture The Journal of the American Medical Association 285 2001 320-323
18. J.A. Kanis O. Johnell A. Oden et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporosis International 12 2001 989-995
19. S.H. Gehlbach C. Bigelow M. Heimisdottir et al. Recognition of vertebral fracture in a clinical setting Osteoporosis International 11 2000 577-582
20. A.R. McLellan S.J. Gallacher M. Fraser et al. C. McQuillian The Fracture Liaison Service: Success of program for evaluation and management of patients with osteoporotic fracture Osteoporosis International 14 2003 1028-1034
21. Osteoporosis Management Systems. www.gismo-glasgow.com.
22. V. Elliot-Gibson E.R. Bogoch S.A. Jamal & D.E. Beaton Practice patterns in the diagnosis and treatment of osteoporosis after a fragiltiy fracture: A systematic review Osteoporosis International 15 2004 767-778
23. S.J. Gallacher I. Baxter A. McLellan et al. Fracture incidence in the City of Glasgow: Analysis by age, sex and socioeconomic deprivation Journal of Bone and Mineral Research 19 supplement 1 2004 M341
24. C.M. Robinson M. Royds A. Abraham et al. Refractures in patients at least forty-five years old. A prospective analysis of twenty-two thousand and sixty patients The Journal of Bone and Joint Surgery 84A 2002 1528-1533